Dissecting Insulin Signaling Pathways: Individualised Therapeutic Targets for Diagnosis and Treatment of Insulin Resistant States

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|9|2|187-198

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.9, Iss.2, 2009-06, pp. : 187-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sphingolipid Signaling Pathways as Potential Therapeutic Targets in Gliomas

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 10, 2007-10 ,pp. : 984-990

Bentham Science Publishers

Access to resources Recommend Favorite

Apoptosis Signaling Pathways as Therapeutic Targets in Lung Injury

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 3, 2004-07 ,pp. : 263-268

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of autism spectrum disorders: neurotransmitter signaling pathways involved in motivation and reward as therapeutic targets

By Walker Michael A  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 949-967

Informa Healthcare

Access to resources Recommend Favorite

Potential Application of Biliverdin Reductase and its Fragments to Modulate insulin/IGF-1/MAPK/PI3-K Signaling Pathways in Therapeutic Settings

By  

Current Drug Targets, Vol. 11, Iss. 12, 2010-12 ,pp. : 1586-1594

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiac Aging and Insulin Resistance: Could Insulin/Insulin-Like Growth Factor (IGF) Signaling be used as a Therapeutic Target?

By  

Current Pharmaceutical Design, Vol. 19, Iss. 32, 2013-10 ,pp. : 5684-5694

Bentham Science Publishers

Access to resources Recommend Favorite